22 1 36 2 10 20170330 PDF
22 1 36 2 10 20170330 PDF
22 1 36 2 10 20170330 PDF
Anisyah Achmad
Laboratorium Famasi Klinik, Jurusan Farmasi Fakultas Kedokteran dan Ilmu- Ilmu
Kesehatan, UNSOED Dr.Soeparno, Kampus Karangwangkal, Purwokerto, Jawa Tengah
( 0281- 642840 ) Telp. 08122582885
Email : r3600mc@yahoo.com
ABSTRACT
Hepatic fibrosis is an inflammation of liver which involves series of cells and mediators.
Hepatic fibrosis can lead to cirrhosis. Hepatic fibrosis increase the risk of clinical
complication such as portal hypertension and hepatocyte disfunction. This study aimed at
finding amarker for non invasive hepatic fibrosis or an antifibrotic by comparison of the
degree of hepatic fibrosis after administration of CCl4 and losartan. Thirty five rat’s were
divided into 7 groups which were K-1, K-2, K-3, K-4, K-5, K-6, K-7 respectively. K-1 was
olive oil control group, K-2, K-3 and K-4 were given CCl4 0,2 ml/100g interperitonially third
a week, K-5, K-6 and K-7 were given CCl4 and losartan 5 mg/Kg BB per oral per day. CCl4
and losartan were given for 6 weeks and the change in rat’s hepatic histopathology was
observed at week 1st, 4th, and 6th. Histopatology of rat’s liver changed from centrotubular
necrosis to centrotubular degeneration but did not show hepatic fibrosis.
cairan yang masuk (Oktavianti, 2005). nekrosis sel yang kerusakannya terlihat
Pada kelompok K-5 yang merupakan jelas pada lobulus zona sentral sedangkan
kelompok terapi losartan juga terjadi pada kelompok K-5 yang merupakan
degenerasi sentrolobular, namun hanya kelompok terapi losartan terlihat kerusakan
sedikit bila dibandingkan dengan jaringan hati hanya sampai tahap
kelompok K-2 yang hanya diinduksi CCl4 degenerasi. Hal ini menunjukan terjadi
tanpa diberi terapi. penurunan keparahan antara kelompok
yang tidak diberi terapi losartan yaitu K-3
dengan kelompok yang diberi terapi
losartan (K-6).